Sixfold Bio raises €108K Seed round
21 March 2018· London, United Kingdom· health, biotechnology, nanotechnology, ai, software_hardware, b2b
To develop customizable nanoparticles for safe and effective delivery of therapeutic and diagnostic molecules to diseased cells, and advance its Mergo® RNA therapeutics delivery platform.
Investors
LeadY Combinator
About Sixfold Bio
Stage
Seed
Headquarters
London, United Kingdom
Founded
2017
Team Size
21–50
Sectors
healthbiotechnologynanotechnologyaisoftware_hardwareb2b